Genetically engineered mouse models with somatic deletion of TP53 and Rb1 in lung are able to recapitulate many clinical manifestations of ASCL1High SCLC, including the extrapulmonary metastases34,35. This evidence concerns the gene RB1 and small cell lung carcinoma.